Chinese researchers develop immunotherapeutic agent for colon cancer
Time:2024-05-22 00:24:39 Source:businessViews(143)
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
share to:
Previous:Socialite Jasmine Hartin enjoys beach snuggle with electrician hunk
Next:Norwegian Cruise Line, Wix.com rise; Cushman & Wakefield, Target fall, Monday, 5/20/2024
Kind tips:The above content and pictures are compiled from the Internet and are for reference only. I hope they will be helpful to you! If there is any infringement, please contact us to delete it.!
You may also like
- Benedict Cumberbatch looks suave as he joins his co
- Rotorua MP seeks extra policing resources for the city
- Immigration declines nearly half of study visa applications from India so far this year
- Fans slam 'JOKE' of a penalty given to Bukayo Saka in footage of the Arsenal star winning a spot
- Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
- Video: How Hong Kong film directors are navigating a new era of censorship
- Kyle Richards rocks a tuxedo while ex
- Hundreds of pests caught travelling along Transmission Gully
- Candice Swanepoel wows in a shimmering black flared jumpsuit as she joins ab